Active, not recruitingNot applicableNCT03412760

Hydrops: Diagnosing & Redefining Outcomes With Precision Study

Studying Hydrops fetalis

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of California, San Francisco
Principal Investigator: Teresa Sparks, MD, MAS
University of California, San Francisco
Intervention: Exome sequencing(diagnostic_test)
Enrollment: 500 enrolled
Eligibility: 18-55 years · All sexes
Timeline: 2018 – 2027

Study locations (1)

University of California, San Francisco, San Francisco, California, United States

Collaborators

National Institutes of Health (NIH) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · Fetal Health Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03412760 on ClinicalTrials.gov

Other trials for Hydrops fetalis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT03911531
Whole Exome Sequencing and Whole Genome Sequencing for Nonimmune Fetal/Neonatal Hydrops
Thomas Jefferson University

See all trials for Hydrops fetalis →

← Back to all trials